Among other findings, the FTC uncovered markups ranging from 188% for MMF as dispensed by a pharmacy benefit manager (PBM)-affiliated pharmacy, to 7,736% for tadalafil. “Remember, these are ...
President Donald Trump’s move to fire two Democrats on the Federal Trade Commission leaves a question mark over the future of ...
A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.
The firing of the Federal Trade Commission’s (FTC’s) two remaining Democratic commissioners Wednesday could raise new, ...
Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management ... investigated by the Federal Trade Commission (FTC).
An owner of several independent pharmacies in Montana says they’re filling more prescriptions than ever but he can’t give ...
Third-party companies known as pharmacy benefit managers, which administer prescription drug benefits for health insurance plans, employers, and other organizations including governments, are driving ...
FIRST ON FOX: A bipartisan group of lawmakers is pushing to reform the incentive structure for Pharmacy Benefit Managers ... to a 2024 report from the Federal Trade Commission.
A pharmacy benefit manager negotiates prices with wholesalers, sets reimbursement rates on drugs and compiles the lists of which medicines an insurer will cover. But critics describe the industry as ...
A 2024 report by the Federal Trade Commission links pharmacy benefit managers to inflated drug prices and claims the companies “may be using their market power across the distribution chain to set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results